is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Showcasing all exhibitor innovations that were submitted for the Pharmapack Awards, the Innovation Gallery gives a great overview of recently launched products. From anti‑counterfeiting and track and trace solutions, to patient adherence and dosage forms, these products represent the ever evolving pharmaceutical packaging and drug delivery industry.
Pharmapack is a great place to learn about the latest developments and new ideas from the industry. You can discuss interesting topics, share your experiences and strengthen relationships with your partners.
Symbioze smart wearable platform is an innovative, large-volume on-body injector to foster patient’s adherence. It offers a great combination between design robustness, ease of use, connectivity, and sustainability, for a seamless and enhanced injection experience.vice can be applied in all types of treatment that requires strict control.
DuoDERM is the first product variant in Pacifi's DuoVIAL® technology portfolio. The DuoVIAL® is designed to Protect, Mix & Deliver, especially sensitive formulations, in a dual-chamber, glass, primary pack format. Combining the advantages of ampoule & vial into a single unit, a more cost effective, safer and easier to use form factor is achieved, whilst maintaining established materials and processes. The unique application of advanced laser technologies (LACR) enables this innovation, evolving the very traditional formats within the pharmaceutical sector. Packaging sustainability is core, wherein the minimal material utilisation, in combination with using 100% recyclable materials (glass & aluminium) and a refill-cartridge approach, minimizes our carbon footprint.
SCHOTT iQ® Integribag’s quality-by-design approach design takes sterility one step further by not only the inside of the RTU tub, but also the outside of the tub and the protective tub layer. This is possible thanks to the bags material, which has a high puncture resistance. It leads to a lower probability of failures and complaints. Additionally, the bags seal is tamper-evident and can easily be inspected by pharma companies as well as CDMOs. With the SCHOTT iQ® Integribag, any additional decontamination steps, such as E-beam or manual alcoholic disinfection wipes, are no longer needed.
The BiKit is a an innovative product, capable of combining two important needs: on the patients' side, the need for better intelligibility of the package leaflet and storage for subsequent consultation. On the pharmaceutical companies' side, the need to have a larger text area and to reduce complexity during the packaging phase, especially for markets that require multi language and/or multi component products.
1 - Hygienic drops for patient protection Pylote technology integration into Rispharm™ allows patients to have hygienic applications for every use with a multidose dropper. Activated Rispharm™ is proven and certified effective against conjunctivitis virus, Escherichia Coli and Staphylococcus aureus bacteria.
2 - Breakthrough sustainable innovation 100% mineral, biocompatible, patented Pylote technology from production to application, manufactured in France using in-house green chemistry process.
3 - An activated multidose dropper: -Self-decontamination of tip and cap
- Identical patient treatment methods
- Same packaging design and use of existing manufacturing/filling lines
- Plastic waste X16 times less for 1-month treatment vs. monodose solutions
In search of a blister solution that meets both environmental requirements and sustainability targets of clients, Huhtamaki and Klöckner Pentaplast teamed up to combine their specific packaging expertise in one product. Huhtamaki Push Tab® blister lid is a 100% mono-PET blister lidding, available with push and peel opening options. In combination with kpNext™ R1 bottom rigid film from Klöckner Pentaplast it makes your package ready for the RIC 1 recycling stream. Additionally, this blister solution works on existing production lines and packaging designs, no compromises in output, no further investments needed. The blister provides a unique product presentation due to its overall superior optical clarity.
The LVI-V20 is a electromechanic wearable injection devices capable of delivering up to 20mL of highly viscous large-molecule drugs into the subcutaneosu tissue. The device is designed so you can continue using any standard glass vial - thus eliminating the need for complex primary container development and validation. This allows for a fast utilisation of this fully programmable and connected device in clinical investigations or lifecycle management initiatives. Since the LVI-V is part of the Sonceboz OBI platform with shared architecture, a transition from LVI-V to say LVI-P is a straightforward process.
Aria is a novel reusable electronic autoinjector, designed to meet current and emerging needs of the self-injection market for biopharmaceuticals. It consists of a reusable electronic power unit, coupled with a disposable cassette, which contains either a 1ml or 2.25mL pre-filled syringe and provides needle safety, using a moveable shield, similar to most disposable devices. The reusable format significantly improves sustainability over conventional disposable autoinjectors, offers built in Bluetooth connectivity and clear audible and visual feedback to guide users through the injection process. It is being developed as a device platform for multiple therapies and pharmaceutical customers
Stoelzle Pharma reached another milestone by developing a new, safe and resource-efficient process for the inner surface treatment of type 2 glass vials. This innovative technique enables reliable and precise dosing tailored to each bottle size, from the smallest 6 ml vials to much bigger. With EcoSecur injection and infusion vials Stoelzle Pharma has reinvented type 2 glass for parenteral and non-parenteral applications.